Abstract
We thank Drs Velonakis, Karavasilis, Almyroudi, Filippiadis, and Korompoki for the in-depth commentary on our article. We value the important observations they made regarding the differences in the rates of leptomeningeal contrast enhancement in patients with coronavirus disease 2019 among the
Highlights
We value the important observations they made regarding the differences in the rates of leptomeningeal contrast enhancement in patients with coronavirus disease 2019 among the included articles in our review
We agree that the large range may be in part because of the differences in MR imaging protocols
It is reasonable to assume that institutions using MR imaging sequences that are more sensitive for detecting leptomeningeal contrast enhancement would report more of it
Summary
We thank Drs Velonakis, Karavasilis, Almyroudi, Filippiadis, and Korompoki for the in-depth commentary on our article. We value the important observations they made regarding the differences in the rates of leptomeningeal contrast enhancement in patients with coronavirus disease 2019 among the included articles in our review.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have